Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Clinical Data Updates & Treatment Management Strategies in First-line ALK-positive Metastatic Non-Small Cell Lung Cancer(NSCLC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    BOOST - Multiple Myeloma An Oncology Boosting Program
    Release Date:
    Review Process: Expert Review Panel
    Translation:(link)
    Quality Improvement Oncology Netherlands
    PARP-Inhibitor Combination Treatments: Safety and Efficacy in a rapidly changing mCRPC landscape
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Education in the Era of Emerging Hemophilia Therapy
    Release Date:
    Partner: National Bleeding Disorders Foundation
    Review Process: Expert Review Panel
    Education Rare Disease Guam, Puerto Rico, USA
    Education for Patients and Caregivers Living with Bladder Cancer from NMIBC to la/mUC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    USP <797> Pharmaceutical Compounding-Sterile Preparations: Ensuring Compliance Now and For the Future
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    COVID-19 Burden and Benefit of Vaccination - Global excluding US, Canada and Taiwan
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Growth Hormone Research
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Efforts for early detection of atrial fibrillation and cardioembolic stroke prevention
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Japan
    Preventing cardiovascular diseases such as venous thromboembolism in cancer patients by raising awareness and promoting medical
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Patient Registries In ATTR-CM
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease Japan
    Optimizing Menopausal Symptom Management in Canada
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine Canada
    Optimizing Menopausal Symptom Management in Canada
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine Canada
    Gene and Anti-TFPI Therapies in Hemophilia
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    Implementing Updated Pneumococcal Immunization Recommendations in Adults
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Vaccines USA
    Employment support / Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Biomarker Testing / Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Cachexia in Cancer – Educational Needs Assessment (USA, Canada, Japan, Italy, UK, Spain, Germany, France)
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Canada, France, Germany, Italy, Japan, Spain, USA, United Kingdom
    Addressing Knowledge Gaps in the Care of Patients with HR-positive/HER2-negative Advanced Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan